Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
This study will compare in-person induction and maintenance dosing of sublingual
buprenorphine to induction and maintenance dosing of sublingual buprenorphine through
comprehensive telehealth sessions and telehealth medication for opioid use disorder (MOUD).